Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros

Métodos Terapéuticos y Terapias MTCI
Bases de datos
País/Región como asunto
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
J Ethnopharmacol ; 263: 113232, 2020 Dec 05.
Artículo en Inglés | MEDLINE | ID: mdl-32768641

RESUMEN

ETHNOPHARMACOLOGICAL RELEVANCE: In Guinea, medicinal plants play an important role in the management of infectious diseases including urinary disorders, skin diseases and oral diseases. This study was carried out to collect medicinal plant species employed for the treatment of these diseases and to investigate their antimicrobial potential. MATERIALS AND METHODS: Based on an ethnobotanical investigation carried out in three Guinean regions, 74 traditional healers and 28 herbalists were interviewed and medicinal plants were collected. The most quoted plant species were evaluated for their antimicrobial activities against Staphylococcus aureus, Escherichia coli, Candida albicans, and in addition against Plasmodium falciparum. RESULTS: A total of 112 plant species belonging to 102 genera distributed over 42 botanical families were inventoried. Among the selected plant species, promising activities against C. albicans were obtained for the methanolic extracts of the stem bark of Terminalia albida (IC50 1.2 µg/ml), the leaves of Tetracera alnifolia (IC50 1.6 µg/ml) and the root bark of Swartzia madagascariensis (IC50 7.8 µg/ml). The highest activity against S. aureus was obtained for the dichloromethane extracts of the leaves of Pavetta crassipes (IC50 8.5 µg/ml) and the root of Swartzia madagascariensis (IC50 12.8 µg/ml). Twenty one extracts, obtained from twelve plant species, were strongly active against Plasmodium falciparum, including the dichloromethane extracts of the root and stem bark of Terminalia albida root (IC50 0.6 and 0.8 µg/ml), the leaves of Landolphia heudelotii (IC50 0.5 µg/ml), the stem bark of Combretum paniculatum (IC50 0.4 µg/ml) and the leaves of Gardenia ternifolia (IC50 1.3 µg/ml). CONCLUSION: The present study provides a comprehensive overview of medicinal plants employed by Guinean traditional healers for the treatment of various microbial diseases, including urinary disorders, skin diseases and oral diseases. Some of the studied plant species showed promising antimicrobial activity and could be considered as a potential source for the development of new antifungal and/or antimalarial agents.


Asunto(s)
Antiinfecciosos/farmacología , Etnobotánica/métodos , Medicinas Tradicionales Africanas/métodos , Extractos Vegetales/farmacología , Plantas Medicinales , Antiinfecciosos/aislamiento & purificación , Etnobotánica/tendencias , Femenino , Fibroblastos/efectos de los fármacos , Fibroblastos/microbiología , Guinea/etnología , Humanos , Masculino , Medicinas Tradicionales Africanas/tendencias , Pruebas de Sensibilidad Microbiana/métodos , Extractos Vegetales/aislamiento & purificación , Plasmodium falciparum/efectos de los fármacos , Plasmodium falciparum/fisiología , Staphylococcus aureus/efectos de los fármacos , Staphylococcus aureus/fisiología
2.
Epilepsy Behav ; 92: 276-282, 2019 03.
Artículo en Inglés | MEDLINE | ID: mdl-30731293

RESUMEN

PURPOSE: The purpose of this study was to characterize the reasons, extent, and impact of traditional medicine use among people with epilepsy (PWE) in the Republic of Guinea. METHODS: Guinea is a low-income country in sub-Saharan Africa (SSA) with limited healthcare resources. People with epilepsy and their caregivers were seen at a public referral hospital in Conakry, the capital city, where they completed semi-structured interviews with physicians regarding their beliefs about epilepsy, medical care, and engagement with traditional healers. RESULTS: Of 132 participants (49% children, 44% female, 55% with a university-educated head of household), 79% had seen a traditional healer, and 71% saw a traditional healer before seeing a medical provider for their epilepsy. Participants were treated by a traditional healer for a mean of 39 months before seeing a medical provider. By contrast, 58% of participants reported taking antiepileptic drugs (AEDs) regularly; 46% reported having undergone a head computed tomography (CT) scan; 58% reported having had an electroencephalogram, and 4% reported having had a brain magnetic resonance imaging (MRI) scan. CONCLUSIONS: Traditional healers in Guinea provide frontline care for PWE in Guinea with considerable delays in AED initiation, even among a cohort of PWE actively seeking medical care. Engaging with these healers is critical for both influencing community perceptions and appropriately managing epilepsy throughout the country.


Asunto(s)
Cuidadores , Epilepsia/etnología , Epilepsia/terapia , Medicinas Tradicionales Africanas/métodos , Adolescente , Adulto , Anticonvulsivantes/uso terapéutico , Cuidadores/psicología , Niño , Preescolar , Estudios de Cohortes , Electroencefalografía/métodos , Epilepsia/diagnóstico por imagen , Femenino , Guinea/etnología , Humanos , Masculino , Derivación y Consulta , Adulto Joven
3.
Rev Mal Respir ; 23(2 Pt 1): 157-60, 2006 Apr.
Artículo en Francés | MEDLINE | ID: mdl-16788441

RESUMEN

INTRODUCTION: Antituberculous treatment is effective but has numerous side effects. Among these isoniazid induced neuropathy is easily preventable. CASE REPORT: A female patient of 42 years, infected with HIV, presented with general deterioration associated with an interstitial pulmonary infiltrate and mediastinal lymphadenopathy. Tuberculosis was not confirmed bacteriologically but she responded to antituberculous treatment. Three months later she developed distal leg pains extending proximally. There was superficial sensory impairment up to the groins and loss of the ankle reflexes. The dose of isoniazid was reduced from 5 to 2.5 mg/kg/day on account of slow acetylator status and treatment with pyridoxine 250 mg/day commenced. The clinical signs resolved in a few weeks. CONCLUSIONS: Isoniazid neuropathy develops in the presence of risk factors (HIV, alcoholism, diabetes, renal failure, malnutrition, pregnancy and lactation, neurotoxic medication) and manifests itself initially by burning feet. Pyridoxine is preventative in low dosage and curative in high dosage. The development of symptoms should lead to measurement of acetylator status, and a reduction of the isoniazid dose to 3 mg/kg/day or even less in slow acetylators.


Asunto(s)
Antituberculosos/efectos adversos , Isoniazida/efectos adversos , Enfermedades del Sistema Nervioso Periférico/inducido químicamente , Deficiencia de Vitamina B 6/inducido químicamente , Vitamina B 6/uso terapéutico , Acetilación , Tendón Calcáneo , Adulto , Terapia Antirretroviral Altamente Activa , Antituberculosos/farmacocinética , Antituberculosos/uso terapéutico , Etambutol/administración & dosificación , Etambutol/uso terapéutico , Femenino , Guinea/etnología , Infecciones por VIH/complicaciones , Infecciones por VIH/tratamiento farmacológico , Hepatitis B Crónica/complicaciones , Humanos , Hipoestesia/inducido químicamente , Hipoestesia/tratamiento farmacológico , Hipoestesia/prevención & control , Inactivación Metabólica/genética , Isoniazida/administración & dosificación , Isoniazida/farmacocinética , Isoniazida/uso terapéutico , Enfermedades del Sistema Nervioso Periférico/tratamiento farmacológico , Enfermedades del Sistema Nervioso Periférico/prevención & control , Reflejo Anormal/efectos de los fármacos , Rifampin/administración & dosificación , Rifampin/uso terapéutico , Tuberculosis Pulmonar/tratamiento farmacológico , Vitamina B 6/farmacocinética , Deficiencia de Vitamina B 6/tratamiento farmacológico , Deficiencia de Vitamina B 6/prevención & control
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA